Chronic Stable Angina Pectoris Clinical Trial
Official title:
Avaliação de episódios Agudos na Angina Pectoris crônica estável: Abordagem clínico-laboratorial do Uso do Vasodilatador Coronariano Propatilnitrato.
This is an open, self-paired study of 200 patients with heart failure who have a diagnosis of chronic stable angina pectoris, who will be treated for 30 days with propatyl nitrate (10mg) . Treatment regimen is 3 sublingual tablets per day, at 8:00 AM, 2:00 PM, and 8:00 PM. The study will include three visits the patient to the study center: Pretreatment / Assessment 1, Assessment 2 after 15 days of treatment, and the Assessment 3 after 30 days of treatment. At each visit, data will be collected on the medical history, physical examination and vital signs, and evaluation of episodes of angina pectoris, as well as the laboratory evaluation of adverse events and the use of concomitant medications.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03914131 -
Clinical Trial Scheme of Xinnaoning Capsule
|
Phase 4 | |
Not yet recruiting |
NCT04264559 -
The Heat Transport Characteristics of the Heart and Lung Meridians: A Study of CSAP Patients and Healthy Adults
|
N/A | |
Recruiting |
NCT04041206 -
A Study on the Microcirculatory Characteristics of Meridian Phenomenon for the Heart and Lung Meridians Based on Patients With Stable Angina Pectoris
|
||
Recruiting |
NCT04041245 -
A Study on the Metabolic Characteristics of Meridian Phenomenon for the Heart and Lung Meridians Based on Patients With Stable Angina Pectoris
|
||
Not yet recruiting |
NCT04244812 -
The Microcirculatory Characteristics of the Heart and Lung Meridians: A Study of CSAP Patients and Healthy Adults
|
N/A | |
Recruiting |
NCT03789552 -
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
|
Phase 3 |